When was LIFEBRAIN acquired by INVESTINDUSTRIAL?

LIFEBRAIN was acquired by INVESTINDUSTRIAL in 2018.

What was the revenue of LIFEBRAIN at the time of the deal?

The revenue of LIFEBRAIN at the time of the deal is estimated to be in the range of 50M - 100M EUR.

How is the data for the LIFEBRAIN acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the LIFEBRAIN deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://bebeez.it/files/2018/04/Antitrust-Lifebrain.pdf

What is the average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026?

The average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026 is 14.5x.

← DATABASE

Home Database Healthcare & PharmaLIFEBRAIN

04/2018

LIFEBRAIN acquired by INVESTINDUSTRIAL

ITALY Health Providers / Healthcare Facilities / Labs (Biology) REV 50M - 100M EUR

Context

Investindustrial acquired a controlling stake in Lifebrain from the investment vehicle lb EK Management. The deal follows a period of intense growth supported by MCI Capital, during which the group established itself as a leading consolidator in the fragmented Italian laboratory market. The acquisition was structured through a Luxembourg vehicle, European Laboratory Services, and aimed to provide the capital and expertise necessary to professionalize the group and accelerate its aggressive acquisition strategy across Italy.

LIFEBRAIN, which reported an EBITDA margin of in 2016, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Healthcare & Pharma sector (14.5x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Lifebrain is Italy's largest provider of clinical laboratory testing services. The group operates a vast network of approximately 360 sites across the country and generates over EUR200 million in revenue. Beyond its core medical diagnostics business, Lifebrain has successfully diversified into environmental and food safety testing markets. Under its previous ownership, the company became a prolific consolidator, completing 70 acquisitions in just three years to achieve its current scale.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2016

2015

Other operations with LIFEBRAIN

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
07/2021	CERBA HEALTHCARE	LIFEBRAIN	ITALY	Labs (Biology)

REFERENCES

Revenue range: 50M - 100M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of LIFEBRAIN by INVESTINDUSTRIAL are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: investindustrial